Healthcare -
Biotechnology - NASDAQ - US
$ 22.93
-3.45 %
$ 438 M
Market Cap
-9.8
P/E
GPCR - STOCK-BASED COMPENSATION
Stock-based Compensation GPCR - Structure Therapeutics Inc.
8.19 M
LAST VALUE
134.70%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR